Central Nervous System (CNS) Stimulant Drugs Market Value Projected to Expand by 2029

Central Nervous System (CNS) stimulant drugs market is expected to grow at a significant CAGR during the forecast period. Stimulant medicines for the CNS are compounds that speed up the body's physical and mental functions. The molecular structure of stimulants is similar to that of monoamine neurotransmitters. These medications are used to treat a variety of medical disorders. Stimulants work through a range of mechanisms. The most prevalent side effect of stimulant medicines is a rise in the level of dopamine, a neurotransmitter that promotes brain activity. Narcolepsy, newborn apnea, lethargy, and other conditions are treated with CNS stimulants. These stimulants are mostly prescribed medications; however, they are frequently used recreationally or without a prescription. 

Increased prevalence of central nervous system illnesses, sleeping disorders, and asthma are some of the primary factors driving the market growth during the forecast period. According to a study conducted by the American Academy of Sleep Medicine in 2016, the prevalence of sleep disorders in the US has increased six-fold, which is expected to drive the global market over the projected period. The industry is also being driven by an increase in mood disorders and post-traumatic stress. Furthermore, due to an increase in the manufacture of stimulants such , as well as an increase in drug trafficking, the illegal drug market is flourishing. Numerous medication adverse effects, such as tachycardia and anxiety, as well as an increase in recreational use and doping, are some factors that could limit the market growth.

To Request a Sample of our Report on Central Nervous System (CNS) Stimulant Drugs Market:  https://www.omrglobal.com/request-sample/central-nervous-system-cns-stimulant-drugs-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered
Regions Covered- Globally

Competitive Landscape: GlaxoSmithKline Plc, Pfizer, Inc.; and Johnson & Johnson Services, Inc.; among others. 

A full Report of Central Nervous System (CNS) Stimulant Drugs Market is Available @  https://www.omrglobal.com/industry-reports/central-nervous-system-cns-stimulant-drugs-market

Central Nervous System (CNS) Stimulant Drugs Market Report Segmentation

By Type 

Amphetamine
Caffeine
Nicotine
Methamphetamine
Others 

By Application 

ADHD
Sleeping Disorder
Depression
Obesity
Respiratory Depression
Others 

 Central Nervous System (CNS) Stimulant Drugs Market by Region

North America                                                                                                           

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/central-nervous-system-cns-stimulant-drugs-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.